Overbrook Management Corp In8 Bio, Inc. Transaction History

Overbrook Management Corp

  • $418 Million
  • Q1 2025

A detailed history of Overbrook Management Corp transactions in In8 Bio, Inc. stock. As of the latest transaction made, Overbrook Management Corp holds 33,756 shares of INAB stock, worth $5,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,756
Previous 33,756 -0.0%
Holding current value
$5,738
Previous $9,000 44.44%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$1.05 - $3.24 $35,443 - $109,369
33,756 New
33,756 $51,000

About IN8BIO, INC.

INAB Quotes by TradingView
  • Ticker INAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,502,200
  • Market Cap $4.17M
  • Description
  • IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...
More about INAB
Track This Portfolio

Track Overbrook Management Corp Portfolio

Follow Overbrook Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Overbrook Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Overbrook Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email